Vandetanib for the treatment of advanced medullary thyroid cancer outside a clinical trial: results from a French cohort. [electronic resource]
Producer: 20160104Description: 386-91 p. digitalISSN:- 1557-9077
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- adverse effects
- Carcinoma, Neuroendocrine -- drug therapy
- Child
- Female
- France
- Humans
- Male
- Middle Aged
- Piperidines -- adverse effects
- Protein Kinase Inhibitors -- adverse effects
- Quinazolines -- adverse effects
- Retrospective Studies
- Risk Factors
- Thyroid Neoplasms -- drug therapy
- Time Factors
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.